{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:46:08Z","timestamp":1769600768291,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.lpm.2011.11.008","type":"journal-article","created":{"date-parts":[[2012,1,14]],"date-time":"2012-01-14T02:24:17Z","timestamp":1326507857000},"page":"276-289","source":"Crossref","is-referenced-by-count":10,"special_numbering":"P1","title":["Atteintes r\u00e9nales des dysglobulin\u00e9mies\u00a0: avanc\u00e9es diagnostiques et th\u00e9rapeutiques"],"prefix":"10.1016","volume":"41","author":[{"given":"Frank","family":"Bridoux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Delbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Sirac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Pourreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Puyade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle","family":"Desport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Jaccard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Fermand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Touchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2011.11.008_bib0005","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ki.1994.355","article-title":"Monoclonal immunoglobulin deposition disease (Randall-type). Relationship with structural abnormalities of immunoglobulin chains","volume":"46","author":"Preud\u2019homme","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2011.11.008_bib0010","series-title":"Monoclonal gammopathies and the kidney","article-title":"Ultrastructural pattern and classification of renal monoclonal immunoglobulin deposits","author":"Touchard","year":"2003"},{"key":"10.1016\/j.lpm.2011.11.008_bib0015","doi-asserted-by":"crossref","unstructured":"Hutchison CA, Batuman V, Behrens J, Bridoux F, Sirac C, Dispenzieri A, et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol;2011 doi:10.1038\/nrneph.2011.168.","DOI":"10.1038\/nrneph.2011.168"},{"key":"10.1016\/j.lpm.2011.11.008_bib0020","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1200\/JCO.2010.30.8791","article-title":"Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group","volume":"28","author":"Dimopoulos","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00005792-200005000-00002","article-title":"Adult Fanconi syndrome secondary to light chain gammapathy: clinicopathologic heterogeneity and unusual features in 11\u00a0patients","volume":"79","author":"Messiaen","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.lpm.2011.11.008_bib0030","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minesota, 1950\u00a0through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2011.11.008_bib0035","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.2010.30.5235","article-title":"Outcome in renal AL amyloidosis after chemotherapy","volume":"29","author":"Pinney","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0045","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MNH.0b013e3280bdc0db","article-title":"New insights into systemic amyloidosis: the importance of diagnosis of specific type","volume":"16","author":"Picken","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.lpm.2011.11.008_bib0055","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2011.11.008_bib0060","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1046\/j.1523-1755.2002.00628.x","article-title":"Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunological features","volume":"62","author":"Bridoux","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2011.11.008_bib0065","series-title":"The kidney in systemic autoimmune diseases","article-title":"Renal disease in cryoglobulinemic vasculitis","author":"Bridoux","year":"2008"},{"key":"10.1016\/j.lpm.2011.11.008_bib0070","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: the disease spectrum","volume":"12","author":"Lin","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0075","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM199311043291905","article-title":"Brief report: heavy chain deposition disease","volume":"329","author":"Aucouturier","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.11.008_bib0080","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits","volume":"20","author":"Nasr","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0085","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2215\/CJN.06180710","article-title":"Glomerulonephritis with isolated C3\u00a0deposits and monoclonal gammopathy: a fortuitous association?","volume":"9","author":"Bridoux","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0090","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-143-11-200512060-00005","article-title":"Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial","volume":"143","author":"Clark","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2011.11.008_bib0095","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","article-title":"Renal failure in multiple myeloma: presenting features and predictors of outcome in 94\u00a0patients from a single institution","volume":"158","author":"Blade","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2011.11.008_bib0100","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1056\/NEJMc1101834","article-title":"Renal improvement in myeloma with bortezomib plus plasma exchange","volume":"364","author":"Burnette","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.11.008_bib0105","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2215\/CJN.04590908","article-title":"Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis","volume":"4","author":"Hutchison","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0110","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1681\/ASN.2010080857","article-title":"Early reduction of serum free light chains associates with renal recovery in myeloma kidney","volume":"22","author":"Hutchison","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3816\/CLM.2009.n.059","article-title":"Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors","volume":"9","author":"Dimopoulos","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.lpm.2011.11.008_bib0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0609.2009.01385.x","article-title":"Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA","volume":"84","author":"Morabito","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0125","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1200\/JCO.2010.28.1238","article-title":"Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study","volume":"28","author":"Ludwig","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2003.04433.x","article-title":"Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy","volume":"122","author":"Lachmann","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0135","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","article-title":"Treatment of 100\u00a0patients with primary amyloidosis: a randomized trial of melphalan, prednisone and colchicine versus colchicine only","volume":"100","author":"Skinner","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2011.11.008_bib0140","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone and melphalan, prednisone and colchicine","volume":"336","author":"Kyle","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.11.008_bib0145","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V91.10.3662","article-title":"Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light chain) amyloidosis: survival and responses in 25\u00a0patients","volume":"91","author":"Comenzo","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2011.11.008_bib0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study","volume":"140","author":"Skinner","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2011.11.008_bib0155","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2003-08-2788","article-title":"Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem-cell transplantation","volume":"103","author":"Palladini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2011.11.008_bib0160","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa070484","article-title":"High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis","volume":"357","author":"Jaccard","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.11.008_bib0165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood-2006-07-035352","article-title":"Safety and efficacy of risk-adapted cyclophosphamide, thalidomide and dexamethasone in systemic AL amyloidosis","volume":"109","author":"Wechalekar","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2011.11.008_bib0170","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood-2010-07-294405","article-title":"Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1\/2\u00a0dose-escalation study","volume":"116","author":"Moreau","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2011.11.008_bib0175","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood-2009-02-203398","article-title":"Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1\u00a0dose-escalation study","volume":"114","author":"Reece","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2011.11.008_bib0180","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1200\/JCO.2009.23.8220","article-title":"Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis","volume":"28","author":"Kastritis","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2011.11.008_bib0185","first-page":"746","article-title":"Melphalan and dexamethasone plus bortezomib induces hematologic and organ responses in AL amyloidosis with tolerable neurotoxicity","volume":"114","author":"Zonder","year":"2009","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.lpm.2011.11.008_bib0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature09494","article-title":"Antibodies to human serum amyloid P component eliminate visceral amyloid deposits","volume":"468","author":"Bodin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2011.11.008_bib0195","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2010.03227.x","article-title":"Solid organ transplantation in AL amyloidosis","volume":"10","author":"Sattianayagam","year":"2010","journal-title":"Am J Transplant"},{"issue":"suppl. 1","key":"10.1016\/j.lpm.2011.11.008_bib0200","first-page":"48","article-title":"Definition of organ involvement and response to treatment in AL amyloidosis: an updated consensus opinion. XII International Symposium on Amyloidosis, Rome, April 18\u201321, 2010","volume":"17","author":"Gertz","year":"2010","journal-title":"Amyloid"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211006233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211006233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T00:10:12Z","timestamp":1640477412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498211006233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0755498211006233"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2011.11.008","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}